News

Filter

Current filters:

PharmaLinkPharmaceutical

US orphan status for Pharmalink’s Busulipo

US orphan status for Pharmalink’s Busulipo

29-10-2013

Swedish specialty pharma group Pharmalink says its product Busulipo, (busulfan), a best-in-class conditioning…

BusulipoNefeconNephrology and HepatologyNorth AmericaOncologyPharmaceuticalPharmaLinkRegulationResearch

Executive appointments at Merck KGaA and Pharmalink

15-11-2011

Germany’s Merck KGaA (MRK: DE) has announced that Joachim Christ will join the company on January…

ManagementMerck KGaAPharmaceuticalPharmaLink

US FDA approves Alkermes’ Vivitrol to treat opioid-dependent patients and orphan status for PharmaLink’s Nefecon

13-10-2010

The US Food and Drug Administration has approved drugmaker Alkermes’ (Nasdaq: ALKS) alcohol dependence…

AlkermesNefeconNeurologicalNorth AmericaPharmaceuticalPharmaLinkRare diseasesRegulationVivitrol

COMPANY SPOTLIGHT

Menarini

Back to top